Pluri Inc. Logo

Pluri Inc.

Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.

PLUR | TA

Overview

Corporate Details

ISIN(s):
US72942G2030
LEI:
Country:
Israel
Address:
Park Building No. 5, 3508409 Haifa

Description

Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 00:23
Immediate Report
English 869.3 KB
2025-12-10 00:23
Immediate Report
English 36.5 KB
2025-12-09 16:31
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic S…
English 130.5 KB
2025-12-09 16:31
Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic S…
English 36.4 KB
2025-12-09 00:29
Other Report or Announcement
English 283.7 KB
2025-12-09 00:29
Other Report or Announcement
English 36.5 KB
2025-12-09 00:26
Other Report or Announcement
English 163.6 KB
2025-12-09 00:26
Other Report or Announcement
English 36.5 KB
2025-12-09 00:25
Other Report or Announcement
English 165.1 KB
2025-12-09 00:25
Other Report or Announcement
English 36.4 KB
2025-12-09 00:23
Other Report or Announcement
English 163.4 KB
2025-12-09 00:23
Other Report or Announcement
English 36.4 KB
2025-12-09 00:22
Other Report or Announcement
English 163.7 KB
2025-12-09 00:22
Other Report or Announcement
English 36.4 KB
2025-12-09 00:21
Other Report or Announcement
English 163.3 KB

Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pluri Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pluri Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Astria Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapies for allergic and immunologic diseases.
United States of America
ATXS
ATAI Life Sciences N.V. Logo
Develops psychedelic-inspired therapies for mental health disorders.
United States of America
ATAI
Atea Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing oral antiviral therapies for serious viral diseases.
United States of America
AVIR
Athira Pharma, Inc. Logo
Biopharma firm developing small molecule therapeutics for neurodegenerative diseases.
United States of America
ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharmaceutical company developing oncology medicines for breast cancer.
United States of America
ATOS
aTYR PHARMA INC Logo
Develops medicines based on tRNA synthetase biology for fibrosis and inflammation.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Develops Virus-Like Drug Conjugates as targeted therapies for solid tumors.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharmaceutical company developing therapies for severe autoimmune diseases.
United States of America
AUPH
AURORA CANNABIS INC Logo
Global producer and distributor of cannabis for medical and recreational markets.
United States of America
ACB
Autolus Therapeutics plc Logo
Biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases.
United States of America
AUTL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.